Curcumin may reduce the cytoplasmic and nuclear translocation of HMGB1-NF-κB, which reduces oxidative stress and blood glucose levels in the liver of NASH patients (103). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.